Publicaciones en colaboración con investigadores/as de Universidad de Granada (17)

2021

  1. MHC heterogeneity and response of metastases to immunotherapy

    Cancer and Metastasis Reviews, Vol. 40, Núm. 2, pp. 501-517

2020

  1. Restoration of mhc-i on tumor cells by fhit transfection promotes immune rejection and acts as an individualized immunotherapeutic vaccine

    Cancers, Vol. 12, Núm. 6, pp. 1-21

2018

  1. MHC intratumoral heterogeneity may predict cancer progression and response to immunotherapy

    Frontiers in Immunology, Vol. 9, Núm. JAN

2014

  1. T lymphocytes restrain spontaneous metastases in permanent dormancy

    Cancer Research, Vol. 74, Núm. 7, pp. 1958-1968

2012

  1. MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells

    Carcinogenesis, Vol. 33, Núm. 3, pp. 687-693

  2. The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells

    Journal of Pathology, Vol. 227, Núm. 3, pp. 367-379

2011

  1. Immunotherapy eradicates metastases with reversible defects in MHC class i expression

    Cancer Immunology, Immunotherapy, Vol. 60, Núm. 9, pp. 1257-1268

2010

  1. Alterations of HLA class i expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity

    Cancer Immunology, Immunotherapy, Vol. 59, Núm. 1, pp. 13-26

  2. The escape of cancer from T lymphocytes: Immunoselection of MHC class i loss variants harboring structural-irreversible "hard" lesions

    Cancer Immunology, Immunotherapy, Vol. 59, Núm. 10, pp. 1601-1606

1996

  1. Effect of in vivo activation of natural killer (NK) cells by a tilorone analogue on the survival of mice injected intravenously with different experimental murine tumours

    Clinical and Experimental Immunology, Vol. 103, Núm. 3, pp. 499-505

1994

  1. In vivo activation of NK cells induces inhibition of lung colonization of H-2 positive and H-2 negative fibrosarcoma tumor clones

    Clinical & Experimental Metastasis, Vol. 12, Núm. 1, pp. 31-36

1993

  1. Generation and control of metastasis in experimental tumor systems; inhibition of experimental metastases by a tilorone analogue

    International Journal of Cancer, Vol. 54, Núm. 3, pp. 518-523

  2. MHC class I expression on prelymphomatous and lymphomatous B-cells is not inhibited by an Eμ-myc transgene

    European Journal of Cancer, Vol. 29, Núm. 2, pp. 238-241

1992

  1. Effect of MHC class‐I transfection on local tumor growth and metastasis in an H‐2‐negative clone derived from a chemically induced fibrosarcoma

    International Journal of Cancer, Vol. 52, Núm. 1, pp. 153-158

1991

  1. Differential mRNA levels of c‐myc, c‐fos and MHC class I in several clones of a murine fibrosarcoma

    International Journal of Cancer, Vol. 49, Núm. 6, pp. 906-910

  2. Heterogeneity of MHC‐class‐I antigens in clones of methylcholanthrene‐induced tumors. Implications for local growth and metastasis

    International Journal of Cancer, Vol. 47, Núm. 6 S, pp. 73-81

1990

  1. A weakly tumorigenic phenotype with high mhc class‐i expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma

    International Journal of Cancer, Vol. 46, Núm. 2, pp. 258-261